SBIO.LSE Invesco NASDAQ Biotech UCITS ETF

ETF Healthcare Equity Invesco Investment Management Limited London Exchange
- USD
No recent price
Total assets
276M
Expense ratio
0.42%
Dividend yield
-
1-year return
+37.02%
Holdings
1
Since
2014

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does SBIO.LSE invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (91.2%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (91.9%)
  • Top 3 holdings: 100.0% of the fund

Asset allocation

  • US stocks 91.2%
  • Non-US stocks 4.9%

Top holdings

  • TRS NASDAQ Biotechnology TR USD 100.00%
All holdings, sectors and regions

Invesco NASDAQ Biotech UCITS ETF performance

Sharpe ratio 0.00
This year
+27.30%
1 year
+37.02%
3 years
+26.15%
5 years
+8.80%

Volatility 15.3% over 1 year and 16.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

SBIO.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.